PPWD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.897400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.688800E-01
Normal-vs-Stage2
3.872000E-01
Normal-vs-Stage3
2.909400E-01
Normal-vs-Stage4
4.312400E-01
Stage1-vs-Stage2
2.746600E-01
Stage1-vs-Stage3
7.797700E-02
Stage1-vs-Stage4
7.551600E-01
Stage2-vs-Stage3
1.155200E-01
Stage2-vs-Stage4
6.102000E-01
Stage3-vs-Stage4
6.815700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.958200E-01
Normal-vs-AfricanAmerican
3.641800E-01
Normal-vs-Asian
3.143600E-01
Caucasian-vs-AfricanAmerican
5.710200E-01
Caucasian-vs-Asian
4.358400E-02
AfricanAmerican-vs-Asian
3.519400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.858200E-01
Normal-vs-Female
3.955000E-01
Male-vs-Female
6.683000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.544000E-01
Normal-vs-Age(41-60Yrs)
4.184400E-01
Normal-vs-Age(61-80Yrs)
3.730600E-01
Normal-vs-Age(81-100Yrs)
3.987200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.692800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.410000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.495200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.138400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.465800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.998400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.601800E-01
Normal-vs-Daily Drinker
3.644600E-01
Normal-vs-Weekly Drinker
3.524600E-01
Normal-vs-Occasional Drinker
3.896600E-01
Normal-vs-Social Drinker
4.473800E-01
Non Drinker-vs-Daily Drinker
9.076800E-01
Non Drinker-vs-Weekly Drinker
8.516600E-01
Non Drinker-vs-Occasional Drinker
5.033800E-01
Non Drinker-vs-Social Drinker
1.118210E-01
Daily Drinker-vs-Weekly Drinker
7.570200E-01
Daily Drinker-vs-Occasional Drinker
5.361800E-01
Daily Drinker-vs-Social Drinker
1.060650E-01
Weekly Drinker-vs-Occasional Drinker
4.230800E-01
Weekly Drinker-vs-Social Drinker
1.154780E-01
Occasional Drinker-vs-Social Drinker
3.039800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.150050E-01
Normal-vs-Grade 2
2.290200E-02
Normal-vs-Grade 3
1.498490E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.221000E-01
Grade 1-vs-Grade 3
8.249800E-01
Grade 1-vs-Grade 4
1.150050E-01
Grade 2-vs-Grade 3
9.927400E-01
Grade 2-vs-Grade 4
2.290200E-02
Grade 3-vs-Grade 4
1.498490E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.841000E-01
Normal-vs-NonDiabetic
3.735000E-01
Diabetic-vs-NonDiabetic
7.042800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.585600E-01
Normal-vs-NoPancreatitis
3.795200E-01
Pancreatitis-vs-NoPancreatitis
5.757400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.063400E-01
Normal-vs-N1
3.809800E-01
N0-vs-N1
3.240800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.712800E-01
Normal-vs-TP53-NonMutant
4.617000E-01
TP53-Mutant-vs-TP53-NonMutant
8.599900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
